Analysis | Samples | Factors | Units |
---|---|---|---|
HILIC NEGATIVE ION MODE | 13_BT474_Gln_fasnall | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:1 uM Fasnall | AU |
HILIC NEGATIVE ION MODE | 16_BT474_Gln_fasnall | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:1 uM Fasnall | AU |
HILIC NEGATIVE ION MODE | 19_BT474_Gln_fasnall | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:1 uM Fasnall | AU |
HILIC NEGATIVE ION MODE | 14_BT474_Gln_GSK | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:1 uM GSK2194069 | AU |
HILIC NEGATIVE ION MODE | 17_BT474_Gln_GSK | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:1 uM GSK2194069 | AU |
HILIC NEGATIVE ION MODE | 20_BT474_Gln_GSK | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:1 uM GSK2194069 | AU |
HILIC NEGATIVE ION MODE | 12_BT474_Gln_contr | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:Vehicle | AU |
HILIC NEGATIVE ION MODE | 15_BT474_Gln_contr | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:Vehicle | AU |
HILIC NEGATIVE ION MODE | 18_BT474_Gln_contr | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:Vehicle | AU |
HILIC NEGATIVE ION MODE | 03_BT474_Gluc_fasnall | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:1 uM Fasnall | AU |
HILIC NEGATIVE ION MODE | 06_BT474_Gluc_fasnall | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:1 uM Fasnall | AU |
HILIC NEGATIVE ION MODE | 09_BT474_Gluc_fasnall | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:1 uM Fasnall | AU |
HILIC NEGATIVE ION MODE | 04_BT474_Gluc_GSK | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:1 uM GSK2194069 | AU |
HILIC NEGATIVE ION MODE | 07_BT474_Gluc_GSK | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:1 uM GSK2194069 | AU |
HILIC NEGATIVE ION MODE | 10_BT474_Gluc_GSK | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:1 uM GSK2194069 | AU |
HILIC NEGATIVE ION MODE | 02_BT474_Gluc_contr | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:Vehicle | AU |
HILIC NEGATIVE ION MODE | 05_BT474_Gluc_contr | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:Vehicle | AU |
HILIC NEGATIVE ION MODE | 08_BT474_Gluc_contr | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:Vehicle | AU |
HILIC NEGATIVE ION MODE | 01_Blank | Sample source:BT-474 | Isotopic Tracer:NA | Drug Treatment:NA | AU |
HILIC NEGATIVE ION MODE | 01_Blank_20220515015111 | Sample source:BT-474 | Isotopic Tracer:NA | Drug Treatment:NA | AU |
HILIC NEGATIVE ION MODE | 11_Blank | Sample source:BT-474 | Isotopic Tracer:NA | Drug Treatment:NA | AU |
HILIC NEGATIVE ION MODE | 21_Blank | Sample source:BT-474 | Isotopic Tracer:NA | Drug Treatment:NA | AU |
HILIC POSITIVE ION MODE | 13_BT474_Gln_fasnall | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:1 uM Fasnall | AU |
HILIC POSITIVE ION MODE | 16_BT474_Gln_fasnall | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:1 uM Fasnall | AU |
HILIC POSITIVE ION MODE | 19_BT474_Gln_fasnall | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:1 uM Fasnall | AU |
HILIC POSITIVE ION MODE | 14_BT474_Gln_GSK | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:1 uM GSK2194069 | AU |
HILIC POSITIVE ION MODE | 17_BT474_Gln_GSK | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:1 uM GSK2194069 | AU |
HILIC POSITIVE ION MODE | 20_BT474_Gln_GSK | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:1 uM GSK2194069 | AU |
HILIC POSITIVE ION MODE | 12_BT474_Gln_contr | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:Vehicle | AU |
HILIC POSITIVE ION MODE | 15_BT474_Gln_contr | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:Vehicle | AU |
HILIC POSITIVE ION MODE | 18_BT474_Gln_contr | Sample source:BT-474 | Isotopic Tracer:[13C5] L-glutamine | Drug Treatment:Vehicle | AU |
HILIC POSITIVE ION MODE | 03_BT474_Gluc_fasnall | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:1 uM Fasnall | AU |
HILIC POSITIVE ION MODE | 06_BT474_Gluc_fasnall | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:1 uM Fasnall | AU |
HILIC POSITIVE ION MODE | 09_BT474_Gluc_fasnall | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:1 uM Fasnall | AU |
HILIC POSITIVE ION MODE | 04_BT474_Gluc_GSK | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:1 uM GSK2194069 | AU |
HILIC POSITIVE ION MODE | 07_BT474_Gluc_GSK | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:1 uM GSK2194069 | AU |
HILIC POSITIVE ION MODE | 10_BT474_Gluc_GSK | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:1 uM GSK2194069 | AU |
HILIC POSITIVE ION MODE | 02_BT474_Gluc_contr | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:Vehicle | AU |
HILIC POSITIVE ION MODE | 05_BT474_Gluc_contr | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:Vehicle | AU |
HILIC POSITIVE ION MODE | 08_BT474_Gluc_contr | Sample source:BT-474 | Isotopic Tracer:[13C6] D-glucose | Drug Treatment:Vehicle | AU |
HILIC POSITIVE ION MODE | 01_Blank | Sample source:BT-474 | Isotopic Tracer:NA | Drug Treatment:NA | AU |
HILIC POSITIVE ION MODE | 01_Blank_20220515015111 | Sample source:BT-474 | Isotopic Tracer:NA | Drug Treatment:NA | AU |
HILIC POSITIVE ION MODE | 11_Blank | Sample source:BT-474 | Isotopic Tracer:NA | Drug Treatment:NA | AU |
HILIC POSITIVE ION MODE | 21_Blank | Sample source:BT-474 | Isotopic Tracer:NA | Drug Treatment:NA | AU |